Back to top

Oppenheimer Maintains Outperform Rating for CRBP, Lowers Price Target | CRBP Stock News

Oppenheimer Maintains Outperform Rating for CRBP, Lowers Price Target | CRBP Stock News

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Corbus Pharmaceuticals Holdings, Inc. (CRBP)